Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
Recovery and Analysis of Bacterial Membrane Vesicle Nanoparticles from Human Plasma Using Dielectrophoresis
Jason P Ware1,2, Delaney K Shea1,2, Shelby L Nicholas1
1Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97201, USA.
Abstract:
Bacterial membrane vesicle (BMV) nanoparticles are secreted naturally by bacteria throughout their lifecycle and are a rich source of biomarkers from the parent bacteria, but they are currently underutilized for clinical diagnostic applications, such as pathogen identification, due to the time-consuming and low-yield nature of traditional recovery methods required for analysis. The recovery of BMVs is particularly difficult from complex biological fluids. Here, we demonstrate a recovery method that uses dielectrophoretic (DEP) forces generated on electrokinetic microfluidic chips to isolate and analyze BMVs from human plasma. DEP takes advantage of the natural difference in dielectric properties between the BMVs and the surrounding plasma fluid to quickly and consistently collect these particles from as little as 25 µL of plasma. Using DEP and immunofluorescence staining of the LPS biomarker carried on BMVs, we have demonstrated a lower limit of detection of 4.31 × 109 BMVs/mL. The successful isolation of BMVs from human plasma using DEP, and subsequent on-chip immunostaining for biomarkers, enables the development of future assays to identify the presence of specific bacterial species by analyzing BMVs from small amounts of complex body fluid.
Insights
Researchers developed a new method using dielectrophoretic (DEP) forces to rapidly isolate bacterial membrane vesicles (BMVs) from human plasma. This technique enhances biomarker recovery for improved pathogen identification in clinical diagnostics.
Area of Science:
- Biotechnology
- Nanotechnology
- Clinical Diagnostics
Background:
- Bacterial membrane vesicles (BMVs) are valuable biomarkers but difficult to recover from biological fluids.
- Traditional BMV recovery methods are time-consuming and low-yield, hindering clinical applications.
Purpose of the Study:
- To develop a rapid and efficient method for isolating and analyzing BMVs from human plasma.
- To enable improved pathogen identification using BMVs as biomarkers.
Main Methods:
- Utilized dielectrophoretic (DEP) forces on electrokinetic microfluidic chips to isolate BMVs.
- Employed immunofluorescence staining for lipopolysaccharide (LPS) biomarker detection.
- Analyzed BMVs from small volumes (25 µL) of human plasma.
Main Results:
- Achieved rapid and consistent collection of BMVs from human plasma using DEP.
- Demonstrated a lower limit of detection of 4.31 × 10^9 BMVs/mL.
- Successfully isolated and performed on-chip immunostaining of BMVs.
Conclusions:
- DEP-based microfluidic chip enables efficient isolation of BMVs from complex biological fluids like plasma.
- This method facilitates the development of novel diagnostic assays for bacterial pathogen identification.
- Advances clinical diagnostics by enabling biomarker analysis from minimal sample volumes.

